Henrietta M. Nielsen
Stockholm University
Henrietta M. Nielsen is listed as Stockholm University. Henrietta is scheduled to speak at AD/PD 2027 – Advances in Science & Therapy on 16 March 2027.
Compiled from published conference agendas; not yet confirmed by Henrietta. Is this you? Claim this profile.
About
Dr Nielsen is an associate professor of Neurochemistry and Molecular Neurobiology at the Department of Biochemistry and Biophysics at Stockholm University (Sweden) and leads the Translational Neurodegeneration Research Laboratory. She earned her PhD in Medicine at Lund University (Sweden) and trained at the VUmc in Amsterdam (the Netherlands), and at the Mayo Clinic in Jacksonville Florida (USA) before starting her laboratory as an interdependent researcher at Stockholm University. The research focus of Dr Nielsen includes APOE, apolipoprotein E biology and peripheral liver-driven phenotypes and processes that may underlie the APOE4-associated increased risk of neurodegenerative disease in different populations. She has a particular interest in the plasma content of apolipoprotein E, its composition and how it relates to Alzheimer’s disease pathology, biomarkers and cognition. Her laboratory utilizes primary human cell cultures, patient-derived tissues and body fluids, and animal model
Upcoming
AD/PD 2027 – Advances in Science & Therapy 16 March 2027 – 20 March 2027
- GLOBAL LEADERSHIP FORUM: MOONSHOTS & MILESTONES: WHO WILL OWN THE FUTURE OF NEURODEGENERATION? Moderator · 16 March 2027
- APOE-DEPENDENT MECHANISMS ACROSS NEURODEGENERATIVE DISEASES Moderator · 17 March 2027